{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:53:38Z","timestamp":1790916818051,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":123,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101239","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:16:06Z","timestamp":1777965366000},"page":"101239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The association of glucose disposal rate on cancer odds mediated by composite inflammatory biomarkers: a cross-sectional study"],"prefix":"10.1016","volume":"48","author":[{"given":"Yingzhe","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangming","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctarc.2026.101239_bib0001","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101239_bib0002","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41577-024-01026-4","article-title":"Vanpouille-Box C. Cancer cell metabolism and antitumour immunity","volume":"24","author":"De Martino","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101239_bib0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12943-024-02216-3","article-title":"Targeting KRAS: from metabolic regulation to cancer treatment","volume":"24","author":"Shi","year":"2025","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101239_bib0004","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2217\/fon-2020-0989","article-title":"DNA damage response alterations in gastric cancer: knocking down a new wall","volume":"17","author":"Ricci","year":"2021","journal-title":"Future Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101239_bib0005","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/10409238.2018.1556578","article-title":"Molecular intricacies of aerobic glycolysis in cancer: current insights into the classic metabolic phenotype","volume":"53","author":"Ganapathy-Kanniappan","year":"2018","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101239_bib0006","article-title":"Landscape of metabolic alterations and treatment strategies in breast cancer","volume":"12","author":"Wu","year":"2025","journal-title":"Genes. Dis."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101239_bib0007","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41467-023-36179-8","article-title":"Epigenetic regulation of neuregulin 1 promotes breast cancer progression associated to hyperglycemia","volume":"14","author":"Lee","year":"2023","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101239_bib0008","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/cac2.12072","article-title":"Is post-transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases?","volume":"40","author":"Brandi","year":"2020","journal-title":"Cancer Commun."},{"key":"10.1016\/j.ctarc.2026.101239_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1362641","article-title":"Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis","volume":"14","author":"Caputo","year":"2024","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101239_bib0010","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ejso.2022.12.006","article-title":"Immunonutrition and prehabilitation in pancreatic cancer surgery: a new concept in the era of ERAS\u00ae and neoadjuvant treatment","volume":"49","author":"De Luca","year":"2023","journal-title":"Eur. J. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101239_bib0011","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/17474124.2021.1864325","article-title":"BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care","volume":"15","author":"Rizzo","year":"2021","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101239_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71746-z","article-title":"Sex differences in adverse events among cancer patients receiving immune checkpoint inhibitors: the MOUSEION-07 systematic review and meta-analysis","volume":"14","author":"Vitale","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101239_bib0013","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11912-022-01344-7","article-title":"Use of antihyperglycemic drugs and risk of cancer in patients with diabetes","volume":"25","author":"S\u00f8ndergaard","year":"2023","journal-title":"Curr. Oncol. Rep."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101239_bib0014","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1210\/endrev\/bnz014","article-title":"Review: diabetes, obesity, and cancer-pathophysiology and Clinical implications","volume":"41","author":"Lega","year":"2020","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101239_bib0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(25)00285-2","article-title":"Trajectories of type 2 diabetes and cancer in 330\u2009000 individuals with prediabetes: 20-year observational study in England","volume":"14","author":"Zaccardi","year":"2026","journal-title":"Lancet Diabetes. Endocrinol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101239_bib0016","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2337\/diabetes.49.4.626","article-title":"Can clinical factors estimate insulin resistance in type 1 diabetes?","volume":"49","author":"Williams","year":"2000","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101239_bib0017","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1111\/dom.13848","article-title":"Double diabetes: a distinct high-risk group?","volume":"21","author":"Kietsiriroje","year":"2019","journal-title":"Diabetes. Obes. Metab."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101239_bib0018","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.2337\/dc24-0475","article-title":"Association of insulin resistance with cardiovascular disease and all-cause mortality in type 1 diabetes: systematic review and meta-analysis","volume":"47","author":"Sun","year":"2024","journal-title":"Diabet. Care."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101239_bib0019","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.13482","article-title":"Estimated glucose disposal rate predicts the risk of diabetic peripheral neuropathy in type 2 diabetes: a 5-year follow-up study","volume":"16","author":"Zhang","year":"2024","journal-title":"J. Diabetes."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101239_bib0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12916-025-04064-4","article-title":"The role of estimated glucose disposal rate in predicting cardiovascular risk among general and diabetes mellitus population: a systematic review and meta-analysis","volume":"23","author":"Guo","year":"2025","journal-title":"BMC. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101239_bib0021","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1186\/s12877-022-03689-x","article-title":"Estimated glucose disposal rate and risk of cardiovascular disease: evidence from the China health and retirement longitudinal study","volume":"22","author":"Ren","year":"2022","journal-title":"BMC. Geriatr."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101239_bib0022","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s12933-024-02485-8","article-title":"Changes in the estimated glucose disposal rate and incident cardiovascular disease: two large prospective cohorts in Europe and Asia","volume":"23","author":"Zheng","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101239_bib0023","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.1007\/s10787-025-01996-4","article-title":"Inflammation and immune biomarkers: new frontiers in understanding and managing diabetes complications","volume":"33","author":"Rao","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101239_bib0024","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cmet.2022.02.015","article-title":"The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming","volume":"34","author":"Hochrein","year":"2022","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101239_bib0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41392-025-02359-9","article-title":"High fructose consumption aggravates inflammation by promoting effector T cell generation via inducing metabolic reprogramming","volume":"10","author":"Ma","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"13","key":"10.1016\/j.ctarc.2026.101239_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202306685","article-title":"Macrophage CREBZF orchestrates inflammatory response to potentiate insulin resistance and type 2 diabetes","volume":"11","author":"Liu","year":"2024","journal-title":"Adv. Sci."},{"issue":"6917","key":"10.1016\/j.ctarc.2026.101239_bib0027","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101239_bib0028","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/cvr\/cvz058","article-title":"Inflammation: a common contributor to cancer, aging, and cardiovascular diseases-expanding the concept of cardio-oncology","volume":"115","author":"Libby","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ctarc.2026.101239_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1408700","article-title":"Prognostic value of inflammatory markers NLR, PLR, and LMR in gastric cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review","volume":"15","author":"Tan","year":"2024","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101239_bib0030","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1111\/dom.15954","article-title":"Association between estimated glucose disposal rate and cardiovascular mortality across the spectrum of glucose tolerance in the US population","volume":"26","author":"Guo","year":"2024","journal-title":"Diabetes. Obes. Metab."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101239_bib0031","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/s41467-026-68355-x","article-title":"Machine learning-predicted insulin resistance is a risk factor for 12 types of cancer","volume":"17","author":"Lee","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101239_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.992566","article-title":"Association between triglyceride glucose index and risk of cancer: a meta-analysis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101239_bib0033","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.tem.2020.05.004","article-title":"Rethinking the relationship between insulin and cancer","volume":"31","author":"Vigneri","year":"2020","journal-title":"Trends. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101239_bib0034","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.cmet.2025.07.008","article-title":"Tumor-associated Schwann cell remodeling under metabolic stress via lactate sensing orchestrates pancreatic ductal adenocarcinoma development","volume":"37","author":"Liu","year":"2025","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101239_bib0035","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41574-024-01057-w","article-title":"Polycystic ovary syndrome as a metabolic disease","volume":"21","author":"Helvaci","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101239_bib0036","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1158\/0008-5472.CAN-24-1185","article-title":"Hypoxia-induced senescent fibroblasts secrete IGF1 to promote cancer stemness in esophageal squamous cell carcinoma","volume":"85","author":"Ou","year":"2025","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.ctarc.2026.101239_bib0037","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.molcel.2023.06.010","article-title":"Glucose-induced CRL4(COP1)-p53 axis amplifies glycometabolism to drive tumorigenesis","volume":"83","author":"Su","year":"2023","journal-title":"Mol. Cell"},{"issue":"21","key":"10.1016\/j.ctarc.2026.101239_bib0038","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1158\/0008-5472.CAN-21-1180","article-title":"Megakaryocytes mediate hyperglycemia-induced tumor metastasis","volume":"81","author":"Wu","year":"2021","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101239_bib0039","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.it.2025.02.014","article-title":"Diabetes can impact cellular immunity in solid tumors","volume":"46","author":"Garstka","year":"2025","journal-title":"Trends. Immunol."},{"issue":"46","key":"10.1016\/j.ctarc.2026.101239_bib0040","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo1673","article-title":"Diabetic hyperglycemia promotes primary tumor progression through glycation-induced tumor extracellular matrix stiffening","volume":"8","author":"Wang","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ctarc.2026.101239_bib0041","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.cell.2025.12.049","article-title":"Hallmarks of cancer-then and now, and beyond","volume":"189","author":"Hanahan","year":"2026","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.ctarc.2026.101239_bib0042","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.3390\/ijms26178256","article-title":"Silent inflammation, loud consequences: decoding NLR across renal, cardiovascular and metabolic disorders","volume":"26","author":"Carollo","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101239_bib0043","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101239_bib0044","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/bjd\/ljaf147","article-title":"Vedel-Krogh S. Low-grade systemic inflammation is associated with risk of psoriasis in a general population study of >100 000 individuals","volume":"193","author":"N\u00e4slund-Koch","year":"2025","journal-title":"Br. J. Dermatol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101239_bib0045","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41571-019-0222-4","article-title":"Tumour-associated neutrophils in patients with cancer","volume":"16","author":"Shaul","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101239_bib0046","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12943-024-02104-w","article-title":"Phenotypic and spatial heterogeneity of CD8(+) tumour infiltrating lymphocytes","volume":"23","author":"Sun","year":"2024","journal-title":"Mol. Cancer"},{"issue":"19","key":"10.1016\/j.ctarc.2026.101239_bib0047","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.3390\/cancers14194892","article-title":"Prognostic value of neutrophil percentage-to-albumin ratio in patients with oral cavity cancer","volume":"14","author":"Ko","year":"2022","journal-title":"Cancers. (Basel)"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101239_bib0048","doi-asserted-by":"crossref","DOI":"10.2144\/fsoa-2021-0008","article-title":"Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy","volume":"7","author":"Ferro","year":"2021","journal-title":"Future Sci. Oa"},{"key":"10.1016\/j.ctarc.2026.101239_bib0049","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1457886","article-title":"Exploring the influence of anemia and inflammation indices on colorectal cancer: analysis of the national health and nutrition examination survey from 2011 to 2018","volume":"14","author":"Qu","year":"2024","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101239_bib0050","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1097\/JS9.0000000000002543","article-title":"Associations of the NPAR index with breast cancer incidence and mortality based on the national health and nutrition examination survey (NHANES) 2001-2018: a cross-sectional study","volume":"111","author":"Su","year":"2025","journal-title":"Int. J. Surg."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101239_bib0051","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1080\/01635581.2017.1367947","article-title":"Clinical value of nutritional status in cancer: what is its impact and how it affects disease progression and prognosis?","volume":"69","author":"Mantzorou","year":"2017","journal-title":"Nutr. Cancer"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101239_bib0052","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.2174\/0109298673286234240123100955","article-title":"Molecular mechanism of breast cancer and predisposition of mouse mammary tumor virus propagation cycle","volume":"32","author":"Ghosh","year":"2025","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101239_bib0053","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41591-020-0856-x","article-title":"Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors","volume":"26","author":"chalper","year":"2020","journal-title":"Nat. Med."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:00:54Z","timestamp":1790913654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226001504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":53,"alternative-id":["S2468294226001504"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101239","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association of glucose disposal rate on cancer odds mediated by composite inflammatory biomarkers: a cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101239"}}